Stage III gastric cancer
Conditions
Interventions
Sponsors
Department of Surgery Graduate School of Medicine, Kyoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Pathologically confirmed gastric cancer 2)cT3/4 or cN2, not Stage IV 3)No previous treatment 4)Age between 20 and 80 years old 5)ECOG 0 or 1 6)Capable of oral administration 7)Informed concent 8)Biology and biochemistry within normal limits
Exclusion criteria
Exclusion criteria: 1)Active bleeding from the tumor 2)Paralysis of intestine or ileus 3)Diarrhea(watery stool) 4)Patient who requires continuous use of flucytosine, phenytoin or warfarin potassium 5)Synchronous multicancer 6)Serous infection 7)Interstitial pneumonitis or fibroid lung 8)Pleural effusion or ascites requiring control 9)Uncontrollable diabetes mellitus, uncontrollable hypertention, heart insufficiency, myocardial infarction within 6 months,uncontrolled arrhythmia or angina 10)Patient who is pregnant or in lactation, or wish to become pregnant during this study.Male patient who intends to make someone pregnant during this study 11)Patient who has experienced serious drug allergy in the past 12)Patient with severe phyciatric disease 13)Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3 year progression free survival rate | — |
Countries
Japan
Outcome results
None listed